Trial intelligence / Profile preview

Aldara to improve influenza vaccination in CLL

NCT00596336Phase 2Terminated

Sponsor
Royal Bournemouth Hospital
Start
Oct 2007
Primary completion
Dec 2011
Countries
1
01

Overview

A Phase 2 trial of imiquimod in influenza, sponsored by Royal Bournemouth Hospital. Started Oct 2007; status: terminated.

02

Drugs

imiquimod
03

Conditions

influenza

Beyond the preview

Go deeper on NCT00596336.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00596336.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call